Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2025-12-25 @ 10:10 PM
NCT ID: NCT00887458
Description: None
Frequency Threshold: 5
Time Frame: 4 years
Study: NCT00887458
Study Brief: A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Low Dose Itraconazole, 200 mg, by mouth, once daily (200 mg total daily dose) Itraconazole 200 mg: Itraconazole, 200 mg, by mouth, once daily (200 mg total daily dose) None None 1 17 14 17 View
High Dose Itraconazole, 300 mg, by mouth, twice daily (600 mg total daily dose) Itraconazole 300mg: Itraconazole, 300 mg, by mouth, twice daily (600 mg total daily dose) None None 0 29 14 29 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
fatigue SYSTEMATIC_ASSESSMENT General disorders CTCAE (3.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
hypokalemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTCAE (3.0) View
rash SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE (3.0) View
hypertension SYSTEMATIC_ASSESSMENT Cardiac disorders CTCAE (3.0) View
fatigue SYSTEMATIC_ASSESSMENT General disorders CTCAE (3.0) View
anorexia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTCAE (3.0) View